Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 331

Results For "treatment"

4041 News Found

Study reveals over 80 % newly diagnosed diabetic patients have at least one cholesterol abnormality
News | April 08, 2022

Study reveals over 80 % newly diagnosed diabetic patients have at least one cholesterol abnormality

The findings support the fact that further extension of nationwide cardiovascular disease (CVD) risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted


JB Chemicals and Pharmaceuticals partners with Akshay Chaitanya to provide free lunch in hospitals
Sustainability | April 07, 2022

JB Chemicals and Pharmaceuticals partners with Akshay Chaitanya to provide free lunch in hospitals

Under this initiative, 700 meals will be provided every day to four hospitals in Mumbai


All India Institute of Ayurveda signs MoU with Safdarjung hospital
News | April 07, 2022

All India Institute of Ayurveda signs MoU with Safdarjung hospital

The MoU sets down the guidelines for the establishment of an integrative medicine unit, joint research and academic activities in various fields of interest in Ayurveda and modern medicine


Alembic gets USFDA tentative approval for dabigatran etexilate capsules
Drug Approval | April 07, 2022

Alembic gets USFDA tentative approval for dabigatran etexilate capsules

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim


New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays
Biotech | April 07, 2022

New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays

The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format


Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19
Drug Approval | April 06, 2022

Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19

Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19


Hataali wins US patent for the use of blockchain in advanced medicinal therapy
Digitisation | April 06, 2022

Hataali wins US patent for the use of blockchain in advanced medicinal therapy

The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award


BioFluidica to introduce next-generation biomarker isolation platform
Biotech | April 06, 2022

BioFluidica to introduce next-generation biomarker isolation platform

BioFluidica LiquidScan harnesses the power of microfluidics


Singlera Genomics announces research collaboration with Astellas Pharma
Biotech | April 06, 2022

Singlera Genomics announces research collaboration with Astellas Pharma

The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals


GE Healthcare and Elekta sign global collaboration agreement
News | April 06, 2022

GE Healthcare and Elekta sign global collaboration agreement

GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets